Promoter characterization of Semaphorin SEMA3F, a tumor suppressor gene

Sophie Kusy, Vincent Potiron, Chan Zeng, Wilbur Franklin, Elisabeth Brambilla, John Minna, Harry A. Drabkin, Joëlle Roche

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

The tumor suppressor gene, Semaphorin SEMA3F, is frequently downregulated in lung cancer. Understanding the specific mechanism of SEMA3F suppression should be informative in terms of epithelial carcinogenesis and potential therapeutic interventions. Although a CpG-island is located 5083-3927 nt upstream of the translation start site, there have been no previous reports dealing with SEMA3F promoter regulation. We have now mapped the transcriptional initiation sites within the CpG-island and defined the region necessary for transcriptional activation. We then looked for evidence of SEMA3F promoter methylation since SEMA3F mutations are rare. By Southern blot and methylation-specific PCR assays, we identified a region in cell lines (i.e., area d at position minus 3850-3644 nt) for which methylation was significantly (P < 0.0001) correlated with loss of expression. However, histone deacetylase inhibition with Trichostatin A was much more effective than 5-aza-2′-deoxycytidine in stimulating SEMA3F. Our results suggest that while SEMA3F promoter methylation correlates with repression, chromatin remodeling through histone deacetylase inhibition is sufficient to activate SEMA3F expression.

Original languageEnglish (US)
Pages (from-to)66-76
Number of pages11
JournalBiochimica et Biophysica Acta - Gene Structure and Expression
Volume1730
Issue number1
DOIs
StatePublished - Jul 25 2005

Fingerprint

Semaphorins
Methylation
Tumor Suppressor Genes
Tumors
Genes
CpG Islands
Histone Deacetylases
decitabine
trichostatin A
Chromatin Assembly and Disassembly
Southern Blotting
Transcriptional Activation
Chromatin
Assays
Lung Neoplasms
Carcinogenesis
Down-Regulation
Chemical activation
Cells
Cell Line

Keywords

  • Epigenetic modifications
  • Lung cancer
  • Reporter gene
  • Semaphorin SEMA3F promoter
  • Transcriptional initiation site

ASJC Scopus subject areas

  • Biochemistry
  • Genetics
  • Structural Biology
  • Biophysics

Cite this

Promoter characterization of Semaphorin SEMA3F, a tumor suppressor gene. / Kusy, Sophie; Potiron, Vincent; Zeng, Chan; Franklin, Wilbur; Brambilla, Elisabeth; Minna, John; Drabkin, Harry A.; Roche, Joëlle.

In: Biochimica et Biophysica Acta - Gene Structure and Expression, Vol. 1730, No. 1, 25.07.2005, p. 66-76.

Research output: Contribution to journalArticle

Kusy, Sophie ; Potiron, Vincent ; Zeng, Chan ; Franklin, Wilbur ; Brambilla, Elisabeth ; Minna, John ; Drabkin, Harry A. ; Roche, Joëlle. / Promoter characterization of Semaphorin SEMA3F, a tumor suppressor gene. In: Biochimica et Biophysica Acta - Gene Structure and Expression. 2005 ; Vol. 1730, No. 1. pp. 66-76.
@article{916c266819544563a6ad45293895f738,
title = "Promoter characterization of Semaphorin SEMA3F, a tumor suppressor gene",
abstract = "The tumor suppressor gene, Semaphorin SEMA3F, is frequently downregulated in lung cancer. Understanding the specific mechanism of SEMA3F suppression should be informative in terms of epithelial carcinogenesis and potential therapeutic interventions. Although a CpG-island is located 5083-3927 nt upstream of the translation start site, there have been no previous reports dealing with SEMA3F promoter regulation. We have now mapped the transcriptional initiation sites within the CpG-island and defined the region necessary for transcriptional activation. We then looked for evidence of SEMA3F promoter methylation since SEMA3F mutations are rare. By Southern blot and methylation-specific PCR assays, we identified a region in cell lines (i.e., area d at position minus 3850-3644 nt) for which methylation was significantly (P < 0.0001) correlated with loss of expression. However, histone deacetylase inhibition with Trichostatin A was much more effective than 5-aza-2′-deoxycytidine in stimulating SEMA3F. Our results suggest that while SEMA3F promoter methylation correlates with repression, chromatin remodeling through histone deacetylase inhibition is sufficient to activate SEMA3F expression.",
keywords = "Epigenetic modifications, Lung cancer, Reporter gene, Semaphorin SEMA3F promoter, Transcriptional initiation site",
author = "Sophie Kusy and Vincent Potiron and Chan Zeng and Wilbur Franklin and Elisabeth Brambilla and John Minna and Drabkin, {Harry A.} and Jo{\"e}lle Roche",
year = "2005",
month = "7",
day = "25",
doi = "10.1016/j.bbaexp.2005.05.008",
language = "English (US)",
volume = "1730",
pages = "66--76",
journal = "Biochimica et Biophysica Acta - Gene Structure and Expression",
issn = "0167-4781",
publisher = "Elsevier BV",
number = "1",

}

TY - JOUR

T1 - Promoter characterization of Semaphorin SEMA3F, a tumor suppressor gene

AU - Kusy, Sophie

AU - Potiron, Vincent

AU - Zeng, Chan

AU - Franklin, Wilbur

AU - Brambilla, Elisabeth

AU - Minna, John

AU - Drabkin, Harry A.

AU - Roche, Joëlle

PY - 2005/7/25

Y1 - 2005/7/25

N2 - The tumor suppressor gene, Semaphorin SEMA3F, is frequently downregulated in lung cancer. Understanding the specific mechanism of SEMA3F suppression should be informative in terms of epithelial carcinogenesis and potential therapeutic interventions. Although a CpG-island is located 5083-3927 nt upstream of the translation start site, there have been no previous reports dealing with SEMA3F promoter regulation. We have now mapped the transcriptional initiation sites within the CpG-island and defined the region necessary for transcriptional activation. We then looked for evidence of SEMA3F promoter methylation since SEMA3F mutations are rare. By Southern blot and methylation-specific PCR assays, we identified a region in cell lines (i.e., area d at position minus 3850-3644 nt) for which methylation was significantly (P < 0.0001) correlated with loss of expression. However, histone deacetylase inhibition with Trichostatin A was much more effective than 5-aza-2′-deoxycytidine in stimulating SEMA3F. Our results suggest that while SEMA3F promoter methylation correlates with repression, chromatin remodeling through histone deacetylase inhibition is sufficient to activate SEMA3F expression.

AB - The tumor suppressor gene, Semaphorin SEMA3F, is frequently downregulated in lung cancer. Understanding the specific mechanism of SEMA3F suppression should be informative in terms of epithelial carcinogenesis and potential therapeutic interventions. Although a CpG-island is located 5083-3927 nt upstream of the translation start site, there have been no previous reports dealing with SEMA3F promoter regulation. We have now mapped the transcriptional initiation sites within the CpG-island and defined the region necessary for transcriptional activation. We then looked for evidence of SEMA3F promoter methylation since SEMA3F mutations are rare. By Southern blot and methylation-specific PCR assays, we identified a region in cell lines (i.e., area d at position minus 3850-3644 nt) for which methylation was significantly (P < 0.0001) correlated with loss of expression. However, histone deacetylase inhibition with Trichostatin A was much more effective than 5-aza-2′-deoxycytidine in stimulating SEMA3F. Our results suggest that while SEMA3F promoter methylation correlates with repression, chromatin remodeling through histone deacetylase inhibition is sufficient to activate SEMA3F expression.

KW - Epigenetic modifications

KW - Lung cancer

KW - Reporter gene

KW - Semaphorin SEMA3F promoter

KW - Transcriptional initiation site

UR - http://www.scopus.com/inward/record.url?scp=22444446949&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=22444446949&partnerID=8YFLogxK

U2 - 10.1016/j.bbaexp.2005.05.008

DO - 10.1016/j.bbaexp.2005.05.008

M3 - Article

C2 - 16005989

AN - SCOPUS:22444446949

VL - 1730

SP - 66

EP - 76

JO - Biochimica et Biophysica Acta - Gene Structure and Expression

JF - Biochimica et Biophysica Acta - Gene Structure and Expression

SN - 0167-4781

IS - 1

ER -